開曼群島 公司法（經修訂） QingSong Health Corporation 輕松健康集團 獲豁免股份有限公司 第八次經修訂及重列組織章程大綱及細則 （根據於2025年12月1日通過的特別決議案採納， 並於股份於香港聯合交易所有限公司主板上市之日起生效） 開曼群島 公司法（經修訂） QingSong Health Corporation 輕松健康集團 的 第八次經修訂及重列組織章程大綱 獲豁免股份有限公司 （根據於2025年12月1日通過的特別決議案採納， 並於股份於香港聯合交易所有限公司主板上市之日起生效） 1 名稱 本公司名稱為輕松健康集團。 2 註冊辦事處 本公司註冊辦事處位於Vistra (Cayman) Limited, P.O. Box 31119, Grand Pavilion Hibiscus Way, 802 West Bay Road, Grand Cayman KY1-1205, Cayman Islands，或董事會可不時決 定的開曼群島境內其他地點。 3 宗旨及能力 在本大綱第8段的規限下，本公司成立的宗旨並無限制，且本公司應有全部權力及 授權實現開曼群島法律並無禁止的宗旨。不 ...

Core Viewpoint - The successful IPO of Qingsong Health Group, a leading digital health service platform in China, reflects strong investor interest and confidence in its business model and growth prospects, with an oversubscription rate of 1421 times for the public offering [1] Company Overview - Qingsong Health Group, established in 2014, integrates health management, insurance technology, and medical services, ranking 10th in the domestic digital comprehensive health service market and 7th in the digital health service market as of 2024 [1][2] Competitive Advantages - The company boasts a large and engaged user base, with 168.4 million registered users, 60.4% of whom are aged 20-45, indicating a strong core consumer demographic [2] - AI technology is deeply integrated across the business chain, with the self-developed AIcare technology stack applied in marketing, underwriting, and health management, contributing over 21% of the lead value [2] - The revenue structure is continuously optimized, with digital comprehensive health service revenue accounting for 76.7% of total revenue, achieving a compound annual growth rate of 221.26% over the past three years [2] Fund Utilization - The funds raised from the IPO will focus on AI technology upgrades, extending health service scenarios, and integrating industry chain resources, aiming to strengthen the full-chain ecosystem of "examination-medication-health-insurance" [2] Industry Outlook - The Chinese digital health industry is experiencing a triple benefit from policy support, demand release, and technological iteration, with the market for comprehensive health services and health insurance expected to reach 11.8 trillion yuan by 2029, growing at a compound annual growth rate of 7.7% from 2024 to 2029 [2] Market Positioning - Qingsong Health Group's unique full-chain service model, AI technology advantages, and high user engagement position it well for industry consolidation, setting a solid foundation for its post-IPO performance in the capital market [3]

Group 1 - The core viewpoint of the article highlights the significant market interest in the IPO of Easy Health, which achieved a subscription amount of HKD 62.04 billion, resulting in an oversubscription rate of 1029.8 times compared to the public offering amount of HKD 60.19 million [1][3] - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise a total of HKD 600 million [3] - The company is expected to officially list on December 23, with CICC and China Merchants Securities International serving as joint sponsors [3] Group 2 - Financial data indicates that Easy Health achieved revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025, respectively [3] - Corresponding net profits for the same periods were RMB 73.616 million, RMB 10.398 million, and RMB 86.045 million [3]

Group 1 - The core viewpoint of the article highlights the successful IPO of Easy Health (02661), which received a subscription of HKD 620.4 billion from brokers, resulting in an oversubscription of 1029.8 times against a public offering amount of HKD 60.19 million [1] - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The company is expected to be listed on December 23, with CICC and China Merchants Securities International as joint sponsors [1] Group 2 - Easy Health, established in 2014, provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research [1] - According to a report by Sullivan, Easy Health ranks 10th in China's digital integrated health services and health insurance market based on projected revenue for 2024, and 7th in the digital health services market [1] - The company, formerly known as "Qing Song Chou," transitioned from being a major online disease crowdfunding platform to a health service provider, obtaining an insurance brokerage license in 2016 and rebranding in 2019 [1] Group 3 - Easy Health has introduced Aoqin Harmony as a cornerstone investor, committing a total investment of RMB 100 million, which translates to 4.8018 million shares at the offering price of HKD 22.68 per share [2] - Financial projections indicate that Easy Health expects revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025, respectively, with corresponding profits of RMB 73.616 million, RMB 10.398 million, and RMB 86.045 million [2] - The net proceeds from the fundraising will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

Core Viewpoint - The company, Easy Health (02661), has successfully completed its IPO subscription, raising significant interest with a total subscription amount of HKD 620.4 billion, leading to an oversubscription rate of 1029.8 times [1] Group 1: IPO Details - The company plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The minimum investment for one lot of shares (200 shares) is HKD 4,581.8, and the company is expected to be listed on December 23 [1] - CICC and China Merchants Securities International are the joint sponsors for the IPO [1] Group 2: Company Background - Easy Health Group was established in 2014, providing comprehensive health and insurance solutions, including early screening, health management, health insurance, and medical research support [1] - The company aims to offer accessible, precise, and affordable health solutions to those in need [1] - Originally known as "Qing Song Chou," the company transitioned to Easy Health Group in 2019, expanding its services across various sectors [1] Group 3: Financial Performance - For the fiscal years ending June 30, 2023, 2024, and 2025, the company reported revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million, respectively [2] - The corresponding profits for the same periods were RMB 73.62 million, RMB 10.40 million, and RMB 86.05 million [2] Group 4: Use of Proceeds - The net proceeds from the IPO will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

Core Viewpoint - The company, Easy Health (02661), has successfully completed its IPO subscription, raising significant interest with a total margin of HKD 62.04 billion and an oversubscription rate of 1029.8 times, indicating strong market demand for its shares [1] Group 1: IPO Details - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The company anticipates its shares will begin trading on December 23, with CICC and China Merchants Securities International acting as joint sponsors [1] Group 2: Company Background - Established in 2014, Easy Health provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research [1] - The company ranks 10th in China's digital integrated health services and health insurance market, and 7th in the digital health services market according to a report by Sullivan [1] Group 3: Financial Information - Easy Health has introduced Aoqin Harmony as a cornerstone investor, committing RMB 100 million, which translates to approximately 4.80 million shares at the IPO price [2] - Projected revenues for Easy Health are approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025 respectively, with corresponding profits of RMB 73.62 million, RMB 10.40 million, and RMB 86.05 million [2] Group 4: Use of Proceeds - The net proceeds from the IPO will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

今日HASHKEY HLDGS(3887.HK)上市，翰思艾泰-B(3378.HK)、轻松健康(2661.HK)、诺比侃 (2635.HK)、华芢生物-B(2396.HK)、明基医院(2581.HK)、南华期货股份(2691.HK)、印象大红袍 (2695.HK)申购。 本文源自：金融界AI电报 ...

Core Viewpoint - The successful IPO of Easy Health Group marks a significant transition from a crowdfunding platform to an AI-driven health management company, aiming to enhance its market position and financial performance [1][11]. Group 1: IPO Success Factors - Easy Health Group has transformed itself into an AI health company, moving away from solely selling insurance and focusing on high-margin technology services, with AIcare technology stack and Dr.GPT for smart consultations and chronic disease monitoring [4]. - The company has shown a strong financial recovery, with a compound annual growth rate (CAGR) of 54.9% in revenue from 2022 to 2024, and a revenue of 656 million yuan in the first half of 2025, representing an 84.7% year-on-year increase [4]. - The backing of prominent investors such as IDG Capital, Tencent, and Sunshine Insurance provides validation of Easy Health's business model and future prospects, instilling confidence in potential investors [5]. Group 2: Challenges Ahead - The separation of the major revenue source, the crowdfunding platform "Qing Song Chou," has led to a decline in active users, dropping from 70.5 million in 2022 to 22.7 million in the first half of 2025, a decrease of 26.5% [8]. - The gross margin has significantly decreased from 82.6% in 2022 to 38.3% in 2024, stabilizing around 32.5% in the first half of 2025, indicating potential profitability challenges [8][9]. - The company faces intense competition in both the insurance and digital health service sectors, with rivals like Waterdrop and Ping An Good Doctor, necessitating strategic adaptations to maintain market relevance [9]. Group 3: Future Prospects - The IPO is expected to provide capital for further technological advancements, with plans to raise up to 601 million HKD, allocating 40% for brand building and user engagement, and 20% for AI and big data capabilities [11]. - The successful IPO signifies regulatory and market recognition of Easy Health's dual business model of digital health services and health insurance, suggesting long-term profitability potential [11]. - With the backdrop of the "Healthy China 2030" initiative and the AI healthcare trend, Easy Health Group is positioned for growth, provided it can enhance its user acquisition strategies [11].

Core Viewpoint - The company, Easy Health Group, has initiated its IPO process, planning to list on the Hong Kong Stock Exchange on December 23, 2025, with a target to raise approximately HKD 600 million through the issuance of 26.54 million shares at a maximum price of HKD 22.68 per share [3][27]. Fundraising and Use of Proceeds - Easy Health aims to raise a net amount of HKD 513 million after deducting listing expenses [3][27]. - The funds will be utilized to enhance brand awareness, increase user engagement, strengthen partnerships, improve technological capabilities in AI and big data, support medical research, and expand into new regions and overseas markets [5][29]. Financial Performance - For the first half of 2025, Easy Health reported revenues of HKD 6.56 billion, a significant increase of 84.8% compared to HKD 3.55 billion in the same period last year [11][34]. - The company achieved a gross profit of HKD 2.13 billion, with a gross margin of 32.5%, down from 49.4% in the previous year [11][34]. - The projected revenues for 2022, 2023, and 2024 are HKD 3.94 billion, HKD 4.9 billion, and HKD 9.45 billion, respectively, with corresponding gross profits of HKD 3.25 billion, HKD 3.91 billion, and HKD 3.62 billion [8][32]. Business Model and Services - Easy Health operates as a technology-driven platform focused on providing comprehensive health services and health insurance solutions [30]. - The company has cultivated a highly engaged user base interested in its health solutions, indicating a strong market presence [32]. Shareholder Structure - Major shareholders include Sun Life Insurance Company with a 10.56% stake and IDG China Media Fund with a 12.89% stake, among others [20][24]. - The founder and CEO, Yang Yin, holds a significant portion of shares, controlling over 30% of the voting rights [17][21].

Core Viewpoint - The company, Easy Health Group, is set to launch its IPO, aiming to raise over HKD 600 million with a market valuation of HKD 4.681 billion, leveraging AI technology as a key growth driver [2][5]. Group 1: IPO Details - Easy Health Group will issue 26,540,000 shares, with 2,654,000 shares available for public offering in Hong Kong and 23,886,000 shares for international offering, priced at HKD 22.68 per share [2]. - The cornerstone investor for this IPO is Guangdong Hengqin Guangdong-Macao Deep Cooperation Zone Aoqin Harmony Investment Partnership, which has subscribed for RMB 100 million [2]. Group 2: Market Position and User Base - According to Sullivan's report, Easy Health Group ranks 10th in China's digital comprehensive health services and health insurance market based on projected 2024 revenue, and 7th in the digital health services market [3]. - As of June 30, 2025, the platform has 168 million registered users and approximately 59.7 million followers across WeChat and other platforms, with 60.4% of users aged between 20 and 45 [3]. Group 3: AI Technology and Innovation - AI technology is a significant growth engine for Easy Health Group, which has developed a proprietary AI technology stack called AIcare, with about 43.3% of its employees in IT R&D [4]. - The company has registered 58 invention patents and 39 software copyrights related to its technology capabilities, enhancing operational efficiency and marketing strategies [4]. Group 4: Financial Performance - Easy Health Group's revenue from 2022 to 2024 is projected to grow from RMB 394 million to RMB 945 million, with a compound annual growth rate of 54.9%, and a year-on-year revenue increase of 84.7% to RMB 656 million in the first half of this year [5]. - The adjusted net profit for the first half of this year is RMB 51.18 million, reflecting an 11.3% year-on-year growth [5].